Dr. Mahmoud Mahfouz, MD

Dr. Mahfouz practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Mahfouz's NPI, 1356893465, was assigned on October 25, 2016. Dr. Mahfouz graduated from University of Aleppo Faculty of Medicine in 2014. Dr. Mahfouz holds Florida license ME137405.

Dr. Mahfouz's primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Dr. Mahfouz's primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. Dr. Mahfouz is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Mahfouz to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahfouz practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mahfouz's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mahfouz is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Mahfouz is licensed in Florida.

Dmand AI lists acid reflux, colonoscopy, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Mahfouz treats.

CMS data shows 162 Medicare services from Dr. Mahfouz across 7 procedure codes in 2024, for 140 Medicare patients. Medicare paid $12,951 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Mahfouz in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahfouz's median patient age at 64, with 49% women.

In 2024, Dr. Mahfouz wrote 73 Medicare Part D claims for 55 patients. 78% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $553 in total drug cost. In 2019, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Mahfouz for performance year 2024, reported as part of a group. Dr. Mahfouz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 159 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mahfouz, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Mahfouz, published from 2019 to 2025. 2019 was the busiest year, with 3. Dr. Mahfouz's most frequent co-authors are Sunil P. Amin, MD, Paul Martin, MD and Kfir Ben-David, MD.

CMS Open Payments shows 38 general payments to Dr. Mahfouz from 13 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 53% of the total. Boston Scientific Corporation paid the most, $3,478.

Dr. Mahfouz graduated from University of Aleppo Faculty of Medicine in 2014.

Dr. Mahfouz is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.